NO940506D0 - Heterocykliske, substituerte fenyl-cykloheksan-karboksylsyrederivater - Google Patents

Heterocykliske, substituerte fenyl-cykloheksan-karboksylsyrederivater

Info

Publication number
NO940506D0
NO940506D0 NO940506A NO940506A NO940506D0 NO 940506 D0 NO940506 D0 NO 940506D0 NO 940506 A NO940506 A NO 940506A NO 940506 A NO940506 A NO 940506A NO 940506 D0 NO940506 D0 NO 940506D0
Authority
NO
Norway
Prior art keywords
cyclohexane
heterocyclic
carboxylic acid
substituted phenyl
acid derivatives
Prior art date
Application number
NO940506A
Other languages
English (en)
Other versions
NO300810B1 (no
NO940506L (no
Inventor
Ulrich E Muller
Jurgen Dressel
Peter Fey
Rudolf H Hanko
Walter Hubsch
Thomas Kramer
Mattias Muller-Gliemann
Martin Beuck
Stanislav Kazda
Stefan Wohlfeil
Andreas Knorr
Johannes-Peter Stasch
Siegfried Zaiss
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO940506D0 publication Critical patent/NO940506D0/no
Publication of NO940506L publication Critical patent/NO940506L/no
Publication of NO300810B1 publication Critical patent/NO300810B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
NO940506A 1993-02-15 1994-02-14 Heterocykliske, substituerte fenylcykloheksankarboksylsyrederivater, samt deres anvendelse i legemidler NO300810B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4304455A DE4304455A1 (de) 1993-02-15 1993-02-15 Heterocyclisch substituierte Phenyl-cyclohexan-carbonsäurederivate

Publications (3)

Publication Number Publication Date
NO940506D0 true NO940506D0 (no) 1994-02-14
NO940506L NO940506L (no) 1994-08-16
NO300810B1 NO300810B1 (no) 1997-07-28

Family

ID=6480447

Family Applications (1)

Application Number Title Priority Date Filing Date
NO940506A NO300810B1 (no) 1993-02-15 1994-02-14 Heterocykliske, substituerte fenylcykloheksankarboksylsyrederivater, samt deres anvendelse i legemidler

Country Status (25)

Country Link
US (1) US5395840A (no)
EP (1) EP0611767B1 (no)
JP (1) JPH06293741A (no)
KR (1) KR940019708A (no)
CN (1) CN1057085C (no)
AT (1) ATE196141T1 (no)
AU (1) AU672262B2 (no)
CA (1) CA2115536C (no)
CZ (1) CZ289096B6 (no)
DE (2) DE4304455A1 (no)
DK (1) DK0611767T3 (no)
ES (1) ES2151908T3 (no)
FI (1) FI106716B (no)
GR (1) GR3034957T3 (no)
IL (1) IL108625A (no)
MY (1) MY131595A (no)
NO (1) NO300810B1 (no)
NZ (1) NZ250864A (no)
PH (1) PH30172A (no)
PL (1) PL177834B1 (no)
PT (1) PT611767E (no)
RU (1) RU2119480C1 (no)
SK (1) SK15294A3 (no)
UA (1) UA35574C2 (no)
ZA (1) ZA94984B (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW300219B (no) * 1991-09-14 1997-03-11 Hoechst Ag
DE19503160A1 (de) * 1995-02-01 1996-08-08 Bayer Ag Verwendung von Phenylcyclohexylcarbonsäureamiden
HRP960015B1 (en) * 1995-02-01 2000-12-31 Bayer Ag Substituted indole derivatives
DE19525028A1 (de) * 1995-07-10 1997-01-16 Bayer Ag Amide und Sulfonamide von heterocyclisch substituierten Benzylaminen
US6143743A (en) 1997-07-03 2000-11-07 Dupont Pharmaceuticals Company Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
US6124463A (en) * 1998-07-02 2000-09-26 Dupont Pharmaceuticals Benzimidazoles as corticotropin release factor antagonists
US6365589B1 (en) 1998-07-02 2002-04-02 Bristol-Myers Squibb Pharma Company Imidazo-pyridines, -pyridazines, and -triazines as corticotropin releasing factor antagonists
SI1131301T1 (sl) * 1998-11-17 2006-02-28 Abbott Gmbh & Co Kg 2-fenilbenzimidazoli in 2-fenilindoli, njihova priprava in uporaba
DE19924818A1 (de) 1999-05-29 2000-11-30 Bayer Ag Substituierte Phenylcyclohexancarbonsäureamide
DE19924819A1 (de) * 1999-05-29 2000-11-30 Bayer Ag Substituierte Phenylcyclohexancarbonsäurebenzylamid (Adenosinaufnahmeinhibitoren)
DE10044792A1 (de) 2000-09-11 2002-04-04 Bayer Ag Substituierte Phenylcyclohexancarbonsäureamide und ihre Verwendung
CN102746088B (zh) * 2006-05-09 2014-09-17 三菱瓦斯化学株式会社 (反式-4-烷基环己基)苯的制备方法
CN104940202B (zh) 2009-06-17 2018-10-16 沃泰克斯药物股份有限公司 流感病毒复制抑制剂
CN103492381A (zh) 2010-12-16 2014-01-01 沃泰克斯药物股份有限公司 流感病毒复制的抑制剂
MX2013015058A (es) 2011-06-24 2014-01-20 Amgen Inc Antagonistas de melastatina 8 de potencial receptor transitorio y su uso en tratamientos.
CA2839699A1 (en) 2011-06-24 2012-12-27 Amgen Inc. Trpm8 antagonists and their use in treatments
UA118010C2 (uk) 2011-08-01 2018-11-12 Вертекс Фармасьютікалз Інкорпорейтед Інгібітори реплікації вірусів грипу
JP6189948B2 (ja) 2012-06-29 2017-08-30 ファイザー・インク ＬＲＲＫ２阻害薬としての新規な４−（置換アミノ）−７Ｈ−ピロロ［２，３−ｄ］ピリミジン
US8952009B2 (en) 2012-08-06 2015-02-10 Amgen Inc. Chroman derivatives as TRPM8 inhibitors
PL3068782T3 (pl) 2013-11-13 2018-12-31 Vertex Pharmaceuticals Incorporated Sposoby wytwarzania inhibitorów replikacji wirusów grypy
NZ719729A (en) 2013-11-13 2022-04-29 Vertex Pharma Inhibitors of influenza viruses replication
US9695171B2 (en) 2013-12-17 2017-07-04 Pfizer Inc. 3,4-disubstituted-1 H-pyrrolo[2,3-b]pyridines and 4,5-disubstituted-7H-pyrrolo[2,3-c]pyridazines as LRRK2 inhibitors
MA42422A (fr) 2015-05-13 2018-05-23 Vertex Pharma Inhibiteurs de la réplication des virus de la grippe
JP6704416B2 (ja) 2015-05-13 2020-06-03 バーテックス ファーマシューティカルズ インコーポレイテッドＶｅｒｔｅｘ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｃｏｒｐｏｒａｔｅｄ インフルエンザウイルスの複製の阻害剤を調製する方法
RU2722149C1 (ru) 2015-09-14 2020-05-27 Пфайзер Инк. Новые производные имидазо[4,5-c] хинолинов и имидазо[4,5-c][1,5] нафтиридинов в качестве ингибиторов LRRK2

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
GB8911854D0 (en) * 1989-05-23 1989-07-12 Ici Plc Heterocyclic compounds
IE64514B1 (en) * 1989-05-23 1995-08-09 Zeneca Ltd Azaindenes
US5164407A (en) * 1989-07-03 1992-11-17 Merck & Co., Inc. Substituted imidazo-fused 5-membered ring heterocycles and their use as angiotensin ii antagonsists
ATE171177T1 (de) * 1990-06-08 1998-10-15 Hoechst Marion Roussel Inc Benzimidazol-derivate, verfahren und zwischenprodukte zu ihrer herstellung, ihre anwendung als arzneimittel und diese enthaltende pharmazeutische zusammensetzungen
RU1836357C (ru) * 1990-07-23 1993-08-23 Др.Карл Томэ ГмбХ Производные бензимидазола, их изомеры, смеси изомеров, гидраты или их физиологически переносимые соли, обладающие антагонистическими в отношении ангиотензина свойствами
EP0470543A1 (de) * 1990-08-10 1992-02-12 Dr. Karl Thomae GmbH Heterocyclische Imidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zur ihrer Herstellung
DE4031635A1 (de) * 1990-10-05 1992-04-09 Thomae Gmbh Dr K Substituierte 1-benzyl-benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
DE4224133A1 (de) * 1992-07-22 1994-01-27 Thomae Gmbh Dr K Benzimidazole, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
DE4200954A1 (de) * 1991-04-26 1992-10-29 Bayer Ag Heterocyclisch substituierte phenylessigsaeurederivate

Also Published As

Publication number Publication date
UA35574C2 (uk) 2001-04-16
DE59409509D1 (de) 2000-10-12
JPH06293741A (ja) 1994-10-21
IL108625A0 (en) 1994-05-30
DE4304455A1 (de) 1994-08-18
US5395840A (en) 1995-03-07
FI940659A (fi) 1994-08-16
PH30172A (en) 1997-01-21
NO300810B1 (no) 1997-07-28
PL177834B1 (pl) 2000-01-31
EP0611767B1 (de) 2000-09-06
FI940659A0 (fi) 1994-02-11
ES2151908T3 (es) 2001-01-16
SK15294A3 (en) 1994-12-07
KR940019708A (ko) 1994-09-14
DK0611767T3 (da) 2001-01-02
CZ289096B6 (cs) 2001-11-14
ZA94984B (en) 1994-08-24
MY131595A (en) 2007-08-30
PT611767E (pt) 2001-02-28
FI106716B (fi) 2001-03-30
AU672262B2 (en) 1996-09-26
GR3034957T3 (en) 2001-02-28
IL108625A (en) 1997-09-30
RU2119480C1 (ru) 1998-09-27
AU5480794A (en) 1994-08-18
ATE196141T1 (de) 2000-09-15
CA2115536A1 (en) 1994-08-16
NZ250864A (en) 1995-03-28
NO940506L (no) 1994-08-16
CZ32994A3 (en) 1994-08-17
PL302213A1 (en) 1994-08-22
CN1108257A (zh) 1995-09-13
CN1057085C (zh) 2000-10-04
CA2115536C (en) 2004-11-02
EP0611767A1 (de) 1994-08-24

Similar Documents

Publication Publication Date Title
NO940506D0 (no) Heterocykliske, substituerte fenyl-cykloheksan-karboksylsyrederivater
NO2004009I1 (no) Melagatran, stereoisomerer derav eller fysiologisksalter eller estrer derav
DE59402222D1 (de) Substituierte heterocyclische Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
NO870241D0 (no) Hypoglykemiske tiazolidindioner.
DK0380331T3 (da) Anvendelse af di-tert.butylhydroxyphenylthioderivater til fremstilling af et lægemiddel til behandling eller forebyggelse af arteriosklerose eller atherosklerose
DE59300135D1 (de) Sulfonylbenzyl-substituierte Benzo- und Pyridopyridone.
ES2105362T3 (es) Nuevos derivados de acidos quinolon- y naftiridoncarboxilicos.
KR910000158A (ko) 의약용 화합물 및 그것의 사용방법
SE8704979D0 (sv) New furanuronic acid derivatives, process for their production and their use
MA21781A1 (fr) Esters ((1,3,5,-triazine-2-yl) aminocarboxyl)-aminosulfonyl) benzoiques herbicides, procedes pour leur preparation et leur utilisation .
ATE308322T1 (de) Arzneimittel zur behandlung der herzinsuffizienz
ATE183088T1 (de) Arzneimittel zur behandlung von hauterkrankungen
AU2443888A (en) Agents for treating high blood pressure and cardiac insufficiency
ATE171704T1 (de) Optisch wirksame alkylendioxybenzolderivate und ihre verwendung als arzneimittel
DE3778642D1 (de) Therapeutikum zur behandlung von magengeschwueren.
ES2117114T3 (es) Nuevos derivados de tiaxolidin-diona, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
ATE44875T1 (de) 4-amino-2-(imidazolidin-2-on-l-yl)-pyrimidin-5carbons|ure-(n-(3-trifluormethyl-phenyl)-amide) zur antithrombotischen prophylaxe und behandlung sowie ihre verwendung zur herstellung von antithrombotisch wirksamen arzneimitteln.
IE860987L (en) Triazole derivatives
ATE118209T1 (de) Pyridin-3-percarboxylsäure monopersulfat.
DK0631777T3 (da) Anvendelse af beta-naphtoquinonderivater til hæmning af blodpladesammenklumpning

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN AUGUST 2002